You are here:
| Reference : Obesite: aspects therapeutiques. |
| Scientific journals : Article | |||
| Human health sciences : Pharmacy, pharmacology & toxicology Human health sciences : Endocrinology, metabolism & nutrition | |||
| http://hdl.handle.net/2268/12118 | |||
| Obesite: aspects therapeutiques. | |
| French | |
| [en] Obesity: therapeutic aspects | |
Scheen, André  [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >] | |
| 2001 | |
| Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique | |
| Académie Royale de Médecine de Belgique | |
| 156 | |
| 10-12 | |
| 471-9; discussion 480-2 | |
| 0377-8231 | |
| Bruxelles | |
| Belgique | |
| [en] Humans ; Life Style ; Obesity/rehabilitation/therapy ; Patient Education as Topic | |
| [en] Obesity is now recognized as a chronic disease. Its treatment implies a prolonged negative energy balance, by reducing caloric intake and/or increasing energy expenditure. In practice, three therapeutic approaches can be considered: 1) life-style modifications, combining well-balanced hypocaloric diet and regular physical exercise, the key-issue in obesity management; 2) in case of failure and as adjunct treatment, anti-obesity drugs, especially orlistat, an intestinal lipase inhibitor, and sibutramine, a central appetite regulator; and 3) in patients with extreme refractory obesity, surgical procedures consisting of gastric restriction (gastroplasty) or intestinal bypass. Anti-obesity treatments must be evaluated in the long run, in terms of efficacy/safety ratio, upon criteria of weight loss, reduction in associated risk factors, improvement of quality of life and, if possible, reduction of morbidity and mortality. | |
| http://hdl.handle.net/2268/12118 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.
